Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimal techniques for arterial gene transfer

L J Feldman1, G Steg

  • 1Cardiology Department, Faculté Xavier Bichat, Hôpital Bichat, Paris, France. laurent.feldman@bch.ap-hop-paris.fr

Cardiovascular Research
|January 31, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Costs of healthcare resource consumption after a myocardial infarction in France: An estimate from a medicoadministrative database (GSB)].

Annales de cardiologie et d'angeiologie·2017
Same author

The de novo origin of the quiescent center regenerating root apices of Zea mays.

Planta·2014
Same author

Cytokinin biosynthesis in roots of corn.

Planta·2013
Same author

Light-induced inhibitors from intact and cultured caps of Zea roots.

Planta·2013
Same author

Light-regulated protein and mRNA synthesis in root caps of maize.

Plant molecular biology·2013
Same author

Abscisic acid, xanthoxin and violaxanthin in the caps of gravistimulated maize roots.

Planta·2013
Same journal

Metabolic crisis and TRPM4 activation cause QT prolongation in TANGO2 deficiency disorder.

Cardiovascular research·2026
Same journal

Personalizing Atrial Fibrillation Therapy: Moving from Genetic Association to Mechanistic Translation.

Cardiovascular research·2026
Same journal

Placental Growth Factor Promotes Endothelial Activation and Inflammatory Remodelling in Pulmonary Hypertension.

Cardiovascular research·2026
Same journal

Endothelial-to-mesenchymal transition (EndMT) in atherosclerosis: mechanisms, models and therapies.

Cardiovascular research·2026
Same journal

The gut-heart axis in cardio-oncology.

Cardiovascular research·2026
Same journal

Proteomic signatures as biomarkers of atherosclerosis burden.

Cardiovascular research·2026
See all related articles

Cardiovascular gene therapy uses improved vectors and delivery methods for treating heart diseases. Safety, efficiency, and cost-effectiveness are key factors for its clinical success.

Area of Science:

  • Cardiovascular Medicine
  • Gene Therapy
  • Biotechnology

Background:

  • Cardiovascular gene therapy is advancing towards clinical application.
  • Numerous cardiovascular diseases are potential targets for gene therapy.
  • Optimizing gene therapy requires tailoring vectors, delivery, and genes to specific conditions.

Purpose of the Study:

  • To review the current state and future prospects of cardiovascular gene therapy.
  • To discuss the challenges and opportunities in vector technology and delivery systems.
  • To highlight the critical factors influencing the clinical adoption of gene therapy for cardiovascular diseases.

Main Methods:

  • Review of current literature on cardiovascular gene therapy.
  • Analysis of different vector systems (adenoviral, non-viral, plasmid DNA).

Related Experiment Videos

  • Evaluation of percutaneous, catheter-based delivery methods.

    • Main Results:

    • Replication-defective adenoviral vectors offer high efficiency but limited duration due to immune response.
    • Non-viral vectors and plasmid DNA are safer but less efficient.
    • Catheter-based delivery is feasible for most cardiovascular applications.

    Conclusions:

    • Cardiovascular gene therapy's future depends on safe and effective delivery systems.
    • Cost-effectiveness compared to alternative therapies is a crucial consideration.
    • Tailoring gene therapy approaches to specific cardiovascular diseases is essential for success.